Association between ICS therapy for COPD and diabetes onset and progression
J. Voorham (Singapore, Singapore), N. Roche (Paris, France), J. Stephens (Swansia, United Kingdom), H. Park (Seoul, Republic of Korea), R. Fogel (East Hanover, United States of America), A. Clemens (Basel, Switzerland), G. Brusselle (Ghent, Belgium), D. Price (Singapore, Singapore)
Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Session: New determinants of cardiovascular morbidity in COPD
Session type: Oral Presentation
Number: 5164
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Voorham (Singapore, Singapore), N. Roche (Paris, France), J. Stephens (Swansia, United Kingdom), H. Park (Seoul, Republic of Korea), R. Fogel (East Hanover, United States of America), A. Clemens (Basel, Switzerland), G. Brusselle (Ghent, Belgium), D. Price (Singapore, Singapore). Association between ICS therapy for COPD and diabetes onset and progression. 5164
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: